Unlike many other chemotherapy drugs that are administered intravenously, Xeloda® (capecitabine) is an oral medication that comes in the form of a tablet (pill). It is approved for use in adults only and is prescribed for the treatment of breast cancer and colorectal cancer.
Xeloda works to fight cancer in a couple of ways. For example, the medication:
Interferes with a cell's ability to make new DNA (molecules that contain the cell's genetic information)
Causes important parts of the cell to stop functioning.
Xeloda is taken by mouth twice a day for two weeks, followed by a one-week break. Common side effects include anemia, nausea, and diarrhea. However, the medicine is generally well tolerated.
(To learn more about taking these pills correctly, click Xeloda. This article offers a complete overview of this product, including information on its effectiveness, overdose information, and safety issues to discuss with your healthcare provider.)
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed May 7, 2007.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click